BERCX
Price
$17.85
Change
+$0.24 (+1.36%)
Updated
Oct 20 closing price
Net Assets
20.76M
JVMRX
Price
$29.91
Change
+$0.32 (+1.08%)
Updated
Oct 20 closing price
Net Assets
23.85B
Interact to see
Advertisement

BERCX vs JVMRX

Header iconBERCX vs JVMRX Comparison
Open Charts BERCX vs JVMRXBanner chart's image
Carillon Chartwell Mid Cap Value I
Price$17.85
Change+$0.24 (+1.36%)
VolumeN/A
Net Assets20.76M
JHancock Disciplined Value Mid Cap R6
Price$29.91
Change+$0.32 (+1.08%)
VolumeN/A
Net Assets23.85B
BERCX vs JVMRX Comparison Chart in %
View a ticker or compare two or three
VS
BERCX vs. JVMRX commentary
Oct 21, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BERCX is a Buy and JVMRX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
JVMRX has more cash in the bank: 23.9B vs. BERCX (20.8M). BERCX pays higher dividends than JVMRX: BERCX (0.94) vs JVMRX (0.84). BERCX was incepted earlier than JVMRX: BERCX (23 years) vs JVMRX (14 years). BERCX (1.35) is less costly to investors than JVMRX (0.75). BERCX (51.00) and JVMRX (49.00) have comparable annual turnover. BERCX has a lower initial minimum investment than JVMRX: BERCX (1000) vs JVMRX (1000000). JVMRX annual gain was more profitable for investors over the last year : -4.82 vs. BERCX (-8.00). JVMRX return over 5 years is better than : 49.24 vs. BERCX (37.32).
BERCXJVMRXBERCX / JVMRX
Total Expense Ratio0.900.74122%
Annual Report Gross Expense Ratio1.350.75180%
Fund Existence23 years14 years-
Gain YTD4.8849.83750%
Front LoadN/AN/A-
Min. Initial Investment100010000000%
Min. Initial Investment IRAN/AN/A-
Net Assets20.8M23.9B0%
Annual Yield % from dividends0.940.84113%
Returns for 1 year-8.00-4.82166%
Returns for 3 years12.0825.7847%
Returns for 5 years37.3249.2476%
Returns for 10 years38.2651.3674%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FGEN11.140.76
+7.27%
FibroGen Inc
JBI10.060.22
+2.24%
Janus International Group
MS161.973.30
+2.08%
Morgan Stanley
G39.860.42
+1.06%
Genpact Limited
WOK0.04N/A
-10.03%
WORK Medical Technology Group Ltd